Nature of the Allograft Responses Th2 Immune Deviation, and the On Histocompatibility Barriers, Th1 to

References es http://www.jimmunol.org/cgi/content/full/161/5/2241#otherarticl16 online articles that cite this article can be accessed at: €http://www.jimmunol.org/cgi/content/full/161/5/2241#BIBL This article cites 34 articles, 19 of which can be accessed free at: Subscriptions online at http://www.jimmunol.org/subscriptions/ Information about subscribing to The Journal of Immunology isPermissions http://www.aai.org/ji/copyright.html Submit copyright permission requests at Email Alerts up at http://www.jimmunol.org/subscriptions/etoc.shtml Receive free email alerts when new articles cite this article. Sign

[1]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[2]  P. Stock,et al.  EVIDENCE FOR DIRECT AND INDIRECT PATHWAYS IN THE GENERATION OF THE ALLOIMMUNE RESPONSE AGAINST PANCREATIC ISLETS , 1991, Transplantation.

[3]  J. Phillips,et al.  T cell regulation in adult transplantation tolerance. , 1996, Journal of immunology.

[4]  P. Nickerson,et al.  The Th1/Th2 paradigm and the allograft response. , 1996, Current opinion in immunology.

[5]  K. Wood,et al.  Indirect presentation of MHC antigens in transplantation. , 1994, Immunology today.

[6]  R. Seder,et al.  Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. , 1996, Journal of immunology.

[7]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[8]  E. Field,et al.  The role of interleukin-4 in the induction phase of allogeneic neonatal tolerance. , 1996, Transplantation.

[9]  P. Nickerson,et al.  IL-2 knockout recipient mice reject islet cell allografts. , 1995, Journal of immunology.

[10]  J. Leonard,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 , 1995, The Journal of experimental medicine.

[11]  R. Lechler,et al.  Presentation and recognition of major and minor histocompatibility antigens. , 1994, Transplant immunology.

[12]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[13]  P. Linsley,et al.  Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. , 1997, Journal of immunology.

[14]  R. Goodman,et al.  IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. , 1996, Journal of immunology.

[15]  B. Konieczny,et al.  Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. , 1992, Transplantation.

[16]  H. Auchincloss,et al.  Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo , 1994, The Journal of experimental medicine.

[17]  D. Abramowicz,et al.  CRITICAL ROLE OF INTERLEUKIN 4 IN THE INDUCTION OF NEONATAL TRANSPLANTATION TOLERANCE , 1995, Transplantation.

[18]  D. Bishop,et al.  Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? , 1997, Transplantation.

[19]  M. Gately,et al.  Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. , 1997, Journal of immunology.

[20]  J. Bradley,et al.  Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. , 1997, Journal of immunology.

[21]  M. Neurath,et al.  Antibodies to interleukin 12 abrogate established experimental colitis in mice , 1995, The Journal of experimental medicine.

[22]  N. Sarvetnick,et al.  Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice , 1996, The Journal of experimental medicine.

[23]  P. Nickerson,et al.  A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. , 1997, Journal of immunology.

[24]  P. Linsley,et al.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.

[25]  N. Sarvetnick,et al.  IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. , 1997, Journal of immunology.

[26]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[27]  P. Nickerson,et al.  Prolonged islet allograft acceptance in the absence of interleukin 4 expression. , 1996, Transplant immunology.

[28]  P. Nickerson,et al.  Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. , 1995, Journal of immunology.

[29]  E. Field,et al.  Prevention of Th1 response is critical for tolerance. , 1996, Transplantation.

[30]  H. Volk,et al.  Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. , 1997, Journal of immunology.

[31]  T. Strom,et al.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Finkelman,et al.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice , 1995, The Journal of experimental medicine.